Coverage, Formulary Restrictions, and Affordability of Sodium-Glucose Cotransporter 2 Inhibitors by US Insurance Plan Types

Autor:	Sri Lekha, Tummalapalli, Julio Lamprea, Montealegre, Neil, Warnock, Michael, Green, Said A, Ibrahim, Michelle M, Estrella
Rok vydání:	2021
Předmět:	Blood Glucose Research Sodium Medicare United States Online Only Cross-Sectional Studies Diabetes Mellitus Type 2 Costs and Cost Analysis Research Letter Humans Hypoglycemic Agents Sodium-Glucose Transporter 2 Inhibitors health care economics and organizations Comments
Zdroj:	JAMA Health Forum
ISSN:	2689-0186
DOI:	10.1001/jamahealthforum.2021.4205
Popis:	This cross-sectional study evaluates the stipulations of coverage under commercial, health insurance exchange, Veterans Affairs, Medicare, Medicaid, or other insurance for canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0882737f4fb7c55084b93fd0ca250c10 https://doi.org/10.1001/jamahealthforum.2021.4205 Zobrazit plný text záznamu